U.S. Honeywell International, Stericycle, Target Corp
Corrects Elf Beauty entry to say TD Cowen raises, not cuts, target price to $235 from $190
June 4 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, including Honeywell International, Stericycle and Target Corp on Tuesday.
HIGHLIGHTS
* Brixmor Property Group Inc BRX.N: Goldman Sachs adds stock to its US conviction list |
* Honeywell International Inc HON.O: RBC cuts target price to $218 from $222 |
* Simon Property Group SPG.N: Goldman Sachs removes stock from its US conviction list |
* Stericycle Inc SRCL.O: RBC cuts to sector perform from outperform |
* Target Corp TGT.N: Goldman Sachs removes stock from its US conviction list |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Agios Pharmaceuticals Inc AGIO.O: Leerink Partners raises PT to $61 from $59 |
* Agios Pharmaceuticals Inc AGIO.O: RBC raises target price to $53 from $44 |
* American Express Co AXP.N: Wells Fargo raises target price to $275 from $265 |
* Arcturus Therapeutics Holdings Inc ARCT.O: Guggenheim raises PT to $71 from $51 |
* Arrowhead Pharmaceuticals Inc ARWR.O: Leerink Partners raises PT to $29 from $27 |
* Autodesk Inc ADSK.O: Mizuho cuts target price to $230 from $270 |
* Black Hills Corp BKH.N: Mizuho raises target price to $57 from $53 |
* Boeing BA.N: Baird cuts target price to $240 from $300 |
* Bowman Consulting Group BWMN.O: Baird initiates coverage with outperform rating; PT $37 |
* Brixmor Property Group Inc BRX.N: Goldman Sachs adds stock to its US conviction list |
* BrownForman Corp BFb.N: JP Morgan cuts target price to $52 from $56 |
* Caribou Biosciences Inc CRBU.O: H.C. Wainwright cuts target price to $9 from $24 |
* Cartesian Therapeutics RNAC.O: Oppenheimer initiates coverage with outperform rating; PT $50 |
* Caseys General Stores Inc CASY.O: Deutsche Bank raises PT to $375 from $337 |
* Cleanspark Inc CLSK.O: JP Morgan cuts target price to $12.5 from $15 |
* Columbus Mckinnon Corp CMCO.O: JP Morgan initiates at overweight rating; PT $53 |
* Crinetics Pharmaceuticals CRNX.O: Oppenheimer raises PT to $74 from $55 |
* Cytokinetics Inc CYTK.O: B. Riley cuts target price to $92 from $122 |
* Draftkings Inc DKNG.O: BofA Global Research adds stock to its US 1 list |
* DT Midstream Inc DTM.N: Wells Fargo raises to overweight from equal weight |
* DT Midstream Inc DTM.N: Wells Fargo raises target price to $77 from $62 |
* Edwards Lifesciences Corp EW.N: Goldman Sachs adds stock to its US conviction list |
* Elevance Health Inc ELV.N: BofA Global Research raises PT to $646 from $621 |
* Elf Beauty Inc ELF.N: TD Cowen raises target price to $235 from $190 |
* Enphase Energy Inc ENPH.O: Goldman Sachs adds stock to its US conviction list |
* EQT Corp EQT.N: Jefferies raises target price to $48 from $43 |
* FedEx Corp FDX.N: BofA Global Research removes stock from its US 1 list |
* First Solar Inc FSLR.O: Goldman Sachs removes stock from its US conviction list |
* First Solar Inc FSLR.O: Morgan Stanley raises target price to $331 from $248 |
* Gates Industrial Corp Plc GTES.N: Barclays cuts target price to $16 from $17 |
* Genmab A/S GMAB.O: Truist Securities raises target price to $53 from $50 |
* Gitlab Inc GTLB.O: Barclays cuts target price to $50 from $55 |
* Gitlab Inc GTLB.O: Barclays cuts target price to $50 from $55 |
* Gitlab Inc GTLB.O: Bernstein cuts target price to $70 from $74 |
* Gitlab Inc GTLB.O: BofA Global Research cuts price objective to $80 from $85 |
* Gitlab Inc GTLB.O: BTIG cuts target price to $58 from $71 |
* Gitlab Inc GTLB.O: D.A. Davidson cuts target price to $50 from $65 |
* Gitlab Inc GTLB.O: Mizuho cuts target price to $62 from $70 |
* Gitlab Inc GTLB.O: Scotiabank cuts target price to $59 from $75 |
* Healthequity Inc HQY.O: BofA Global Research raises PT to $105 from $97 |
* Healthequity Inc HQY.O: Wells Fargo raises target price to $107 from $105 |
* Heico Corp HEI.N: Morgan Stanley raises target price to $225 from $178 |
* Heico Corp HEI.N: Morgan Stanley raises target price to $225.00 from $178.00 |
* Heico Corp HEI.N: Morgan Stanley raises to equal-weight from underweight |
* Honeywell International Inc HON.O: Deutsche Bank raises PT to $224 from $219 |
* Honeywell International Inc HON.O: JP Morgan raises PT to $225 from $220 |
* Honeywell International Inc HON.O: RBC cuts target price to $218 from $222 |
* Howard Hughes Holdings Inc HHH.N: Jefferies cuts target price to $80 from $89 |
* Humana Inc HUM.N: Stephens raises target price to $400 from $350 |
* Ideaya Biosciences Inc IDYA.O: Stifel raises target price to $63 from $55 |
* Illinois Tool Works Inc ITW.N: Barclays cuts target price to $217 from $229 |
* Kinder Morgan Inc KMI.N: Wells Fargo raises to overweight from equal weight |
* Kinder Morgan Inc KMI.N: Wells Fargo raises target price to $22 from $18 |
* Kirby Corp KEX.N: BofA Global Research adds stock to its US 1 list |
* Lavoro Ltd LVRO.O: Oppenheimer cuts target price to $9 from $11 |
* Liberty Media Corp FWONK.O: Evercore ISI raises target price to $90 from $85 |
* Marathon Digital Holdings Inc MARA.O: JP Morgan cuts target price to $14 from $16.5 |
* Marvell Technology Inc MRVL.O: BofA Global Research removes stock from its US 1 list |
* Nvidia Corp NVDA.O: BofA Global Research adds stock to its US 1 list |
* Nvidia Corp NVDA.O: Mizuho raises target price to $1275 from $1180 |
* Oklo Inc OKLO.N: Citigroup initiates with neutral rating; price target $11 |
* Omega Healthcare Investors Inc OHI.N: Deutsche Bank raises PT to $38 from $36 |
* Parker-Hannifin Corp PH.N: Barclays cuts target price to $610 from $618 |
* Procore Technologies Inc PCOR.N: Mizuho cuts target price to $70 from $75 |
* Procore Technologies Inc PCOR.N: Mizuho cuts to neutral from buy |
* PTC Inc PTC.O: Mizuho cuts target price to $190 from $200 |
* PTC Inc PTC.O: Mizuho cuts to neutral from buy |
* Qualcomm Inc QCOM.O: TD Cowen raises target price to $235 from $200 |
* Regal Rexnord Corporation RRX.N: Barclays cuts target price to $181 from $199 |
* Regeneron Pharmaceuticals Inc REGN.O: RBC raises target price to $1,200 from $1,185 |
* Rezolute Inc RZLT.O: Craig-Hallum initiates coverage with buy rating; PT $14 |
* Riot Platforms Inc RIOT.O: JP Morgan cuts target price to $12 from $15.5 |
* Rockwell Automation Inc ROK.N: Barclays cuts target price to $250 from $260 |
* Sallie Mae SLM.O: TD Cowen raises target price to $27 from $25 |
* Science Applications International Corp SAIC.O: Truist Securities cuts PT to $125 from $130 |
* Sempra SRE.N: Goldman Sachs adds stock to its US conviction list |
* Sentinelone Inc S.N: Canaccord Genuity cuts target price to $23 from $28 |
* Sentinelone Inc S.N: Canaccord Genuity raises to buy from hold |
* Silvaco Group Inc SVCO.O: Craig-Hallum initiates coverage with buy rating; PT $25 |
* Simon Property Group Inc SPG.N: Goldman Sachs removes stock from its US conviction list |
* Skywest Inc SKYW.O: TD Cowen raises target price to $95 from $85 |
* Southern Co SO.N: Goldman Sachs removes stock from its US conviction list |
* Stanley Black & Decker Inc SWK.N: Barclays cuts target price to $86 from $100 |
* Stanley Black & Decker Inc SWK.N: Barclays cuts to equal-weight from overweight |
* Stericycle Inc SRCL.O: RBC cuts target price to $62 from $69 |
* Stericycle Inc SRCL.O: RBC cuts to sector perform from outperform |
* Stericycle Inc SRCL.O: Truist Securities raises target price to $62 from $50 |
* Structure Therapeutics Inc GPCR.O: Leerink Partners raises PT $93 from $58 |
* Sunoco LP SUN.N: Mizuho cuts target price to $59 from $60 |
* Sunoco LP SUN.N: Mizuho raises to buy from neutral |
* Superior Group of Companies Inc SGC.O: D.A. Davidson initiates coverage with buy rating; PT $24 |
* Target Corp TGT.N: Goldman Sachs removes stock from its US conviction list |
* Teradyne Inc TER.O: Goldman Sachs adds stock to its US conviction list |
* Toll Brothers Inc TOL.N: KBW raises target price to $142 from $135 |
* Transmedics Group Inc TMDX.O: Stephens initiates with overweight rating; PT $151 |
* Vail Resorts Inc MTN.N: Deutsche Bank cuts target price to $226 from $244 |
* Waste Management Inc WM.N: Deutsche Bank cuts target price to $233 from $241 |
* Wendy's Co WEN.O: Guggenheim cuts target price to $22 from $23 |
* Williams Companies Inc WMB.N: Wells Fargo raises to overweight from equal weight |
* Williams Companies Inc WMB.N: Wells Fargo raises target price to $46 from $38 |
* Zscaler Inc ZS.O: Canaccord Genuity cuts target price to $220 from $260 |
(Compiled by Bengaluru Newsroom)
</body></html>Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
